2022 annual financial data
Rein Therapeutics 2022 Operating margin
Rein Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -27,647 USD and net income was -27,329 USD.
Operating cash flow was -24,865,000 USD.
Get free Rein Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -27,647 USD
- Net income
- -27,329 USD
- Operating cash flow
- -24,865,000 USD